Daniel Baumann
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
-
- Immune cells in cancer
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 2
-
- Immunotherapy and Immune Responses 3
- Immune cells in cancer 3
- Phagocytosis and Immune Regulation 2
- Co-authors
- Rienk Offringa (8 shared papers)Claus Bachert (2 shared papers)Petra Högger (2 shared papers)O. Strohmeier (2 shared papers)Tobias Hutzenlaub (2 shared papers)Fabian Stumpf (2 shared papers)Daniel Mark (2 shared papers)Felix von Stetten (2 shared papers)
- Journals
- Scientific Reports (2 papers)Cancer Research (2 papers)Cancer Discovery (1 paper)The Journal of Cell Biology (1 paper)Nature Communications (1 paper)
- Partner nations
- GermanyBelgiumUnited States
In The Last Decade
Daniel Baumann
21 papers receiving 709 citations
Peers
Comparison fields: 5 of 106
- Oncology 183
- Immunology 100
- Pharmaceutical Science 25
- Molecular Biology 276
- Toxicology 13
Countries citing papers authored by Daniel Baumann
This map shows the geographic impact of Daniel Baumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Baumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Baumann more than expected).
Fields of papers citing papers by Daniel Baumann
This network shows the impact of papers produced by Daniel Baumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Baumann. The network helps show where Daniel Baumann may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Baumann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 116 | |
| 2 | [New drugs. 3]. | 1970 | 80 |
| 3 | [New drugs. 5]. | 1971 | 67 |
| 4 | [New drugs. 6]. | 1971 | 67 |
| 5 | [New drugs. 8]. | 1972 | 65 |
| 6 | [New drugs. 9]. | 1973 | 61 |
| 7 | 2020 | 51 | |
| 8 | 2013 | 46 | |
| 9 | 2021 | 34 | |
| 10 | 2009 | 29 | |
| 11 | 2020 | 21 | |
| 12 | 2020 | 17 | |
| 13 | 2018 | 15 | |
| 14 | A double-antibody sandwich ELISA for the detection of Entamoeba histolytica antigen in stool samples of humans. | 1987 | 14 |
| 15 | 2020 | 12 | |
| 16 | 1975 | 11 | |
| 17 | 2011 | 8 | |
| 18 | 1976 | 4 | |
| 19 | 2015 | 3 | |
| 20 | 1976 | 2 |
About Daniel Baumann
Daniel Baumann is a scholar working on Oncology, Immunology, Molecular Biology, Organic Chemistry and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 726 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Magnetism in coordination complexes (3 papers), Immunotherapy and Immune Responses (3 papers), Immune cells in cancer (3 papers), Organometallic Complex Synthesis and Catalysis (3 papers), Allergic Rhinitis and Sensitization (2 papers), Phagocytosis and Immune Regulation (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Oncology (183 citations), Immunology (100 citations), Pharmaceutical Science (25 citations), Molecular Biology (276 citations) and Toxicology (13 citations). Daniel Baumann has collaborated with scholars based in Germany, Belgium and United States. Frequent co-authors include Rienk Offringa, Claus Bachert, Petra Högger, O. Strohmeier, Tobias Hutzenlaub, Fabian Stumpf, Daniel Mark, Felix von Stetten, F. Schwemmer and Roland Zengerle. Their work appears in journals such as Scientific Reports, Cancer Research, Cancer Discovery, The Journal of Cell Biology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.